Hematology Diagnostics Market

Hematology Diagnostics Market: Rising Popularity of Medical Tourism Providing Impetus to Market Growth: Global Industry Analysis (2013-2017) and Opportunity Assessment (2018-2026)

Ask The Analyst Customization Available Request Methodology

Hematology Diagnostics Market- Prevalence of Blood-Related Disorders to Propel Demand

Hematology refers to a diagnostic bifurcation of cells found in the blood, which is helpful for easy and effective identification of various disease-causing pathogens. The process of hematology diagnosis consists of the calculation of RBC, WBC, and platelet count. The hematology diagnosis process is associated with effective monitoring of diseases, prognosis & diagnosis, and subsequent screening. Growing prevalence of blood-related disorders and rising demand for technologically-advanced methodologies are among the prime factors fuelling investments in hematology diagnosis market.

Rising consolidation among leading market players & diagnostic laboratories is another chief aspect predominantly responsible for growth of hematology diagnostics market over the forecast period. Ever-evolving expansion of the hematology diagnostics market can be ascribed to rise in prevalence of blood-related disorders, which, in turn, results in augmented demand for effective diagnostics, such as hematology diagnostics.

Hematology Diagnostics Market- Manufacturers to Focus on Novel Product Developments Aligned with End-User Requirements

Sensing varying requirements of end-users, the manufacturers operating in the hematology market are vying to offer new products well-aligned with end-user requirements. This is resulting in an extensive inflow of new analyzers and combinations with effective functionalities and testing parameters. Moreover, key companies operating in the hematology diagnostics market are vying to be cost-competitive by commercializing their products at competitive prices.

With on-going developments in the flow cytometry procedures and techniques, manufacturers in the hematology diagnostics market are offering differential equipment for effective identification and detection of immature cells. In addition, with various improvement in case of electronic-fluidic systems, demand from laboratories for compact and cost-effective hematology diagnostics equipment is significantly taking off.

Hematology Diagnostics Market- Ubiquitous Demand for Medical Tourism to Boost Growth

Affordability combined with easy accessibility of effective healthcare services is resulting in heightened demand for medical tourism and medical equipment, including hematology diagnostics systems. Growing prevalence of blood-associated disorders in remote areas and skyrocketing demand for effective diagnosis via medical tourism is likely to provide impetus to growth of hematology diagnostics market. Availability of latest and advanced equipment & technologies has restored the confidence of patients to opt for medical tourism hubs, creating opportunities for manufacturers in hematology diagnostics market. 

Hematology Diagnostics Market- North America Continues to Retain its Lucrativeness, US and Canada to Offer Profit-Making Opportunities

North America continues to retain its position as a lucrative market for hematology diagnostics, offering sustained opportunities for the key stakeholders of hematology diagnostics market. With a major chunk of the global market share in 2017, multimodal factors, including advancements in healthcare space, high awareness ratio, and favorable reimbursement scenarios, are making North America a profitable region in the hematology diagnostics market space.

The U.S. & Canada continue to be progressive North American countries staying at the forefront of research and technological innovations, offering immense scope for revenue growth of hematology diagnostics market. This, in turn, is encouraging the participants of hematology diagnostics market to expand their foothold and tap into new customer segments across the key countries of North America.

Hematology Diagnostics Market- The Competitive Landscape

The report on hematology diagnostics market profiles key companies operating in the global market space, by analyzing their key differential strategies. Some of the leading players operating in the hematology diagnostics market include Sysmex Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers, HemoCue AB, HORIBA, Ltd., Danaher (Beckman Coulter, Inc.), and others.

The leading market players are investing in research and development and embracing advanced technologies, with an objective of diversifying their product portfolio, expanding their customer outreach, and extend their regional presence.

The report on hematology diagnostics market offers an incisive analysis of the global hematology diagnostics market over the forecast period of 2018 to 2026. The report on hematology diagnostics market sheds light on prime opportunities brimming in the hematology diagnostics market during the forecast timespan, for the readers to take into account. The report on hematology diagnostics market offers a deep-dive into a comprehensive segmental analysis, wherein every segment has been analyzed and presented on the basis of their attractiveness in the hematology diagnostics market space.

The segmentation offered in the research study on hematology diagnostics market is presented on the basis of end-user, product type, and region. On the basis of product type, the hematology diagnostics market has been bifurcated into hematology consumables and hematology instruments. On the basis of end-user, the hematology diagnostics market has been bifurcated on diagnostic laboratories, academic institutes, hospitals & clinics, and others. On the basis of region, the hematology diagnostics market has been gauged across regions of North America, Asia Pacific, Latin America, Europe, and MEA (Middle East & Africa).

The research methodology for hematology diagnostics market report is solely based on both primary and secondary research phases, which are the key steps carried out to garner useful insights with respect to hematology diagnostics market growth. The insights collected and compiled in the hematology diagnostics market report are instrumental for analyzing growth of hematology diagnostics market. Primary research represents a crucial part of the overall research methodology for hematology diagnostics market report, wherein in-person interviews and constructive discussions with industry experts and opinion leaders are carried out. The phase of secondary research consists of a comprehensive study of various relevant sources, including annual reports, investor presentations, paid databases, and company websites. The report on hematology diagnostics market gives data insights, for both value and volume, and also considers the macro and micro economic trends for determining growth of hematology diagnostics market.

The research report on hematology diagnostics market comprises of a detailed executive summary, wherein a quick snapshot is offered to understand the market progress. The executive summary also comprises of information and insights on various market segments, wherein different segments along with their growth prospects have been analyzed. The various products segments analyzed in detail in the hematology diagnostics market report include product type, region, and end-user. The section of market overview in the hematology diagnostics market report offers a detailed analysis of the market dynamics, including trends, opportunities, challenges, and drivers, which play a profound role in shaping growth of hematology diagnostics market. The report on hematology diagnostics market also offers a model of Porter’s five forces, which offers a deep-dive into the competitive landscape of hematology diagnostics market.

The competitive landscape section in the hematology diagnostics market report offers a detailed analysis of market share of various players operating in the global market space, along with other details such as differential strategies, revenue details, regional presence, and product developments. On the basis of region, the growth of hematology diagnostics market has been analyzed and examined across various key regions, including North America, Asia Pacific, Latin America, Europe, and MEA (Middle East & Africa). The regional analysis in the hematology diagnostics market report offers a comprehensible view of various countries and associated growth opportunities for the better understanding of readers.

The report on hematology diagnostics market also includes profiles of  leading players operating in the market on the basis of multiple aspects, including company and financial overview, product portfolios, differential strategies, and novel product developments.

Hematology Diagnostics Market Reports - Table of Contents

Section 01 Preface 

1.1 Report Scope and Market Segmentation 

1.2 Research Highlights

Section 02 Assumptions and Research Methodology 

2.1 Assumptions

2.2 Research Methodology

Section 03 Executive Summary

3.1 Global Hematology Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2017 and 2026

3.2 Global Hematology Diagnostics Market Snapshot, 2017

3.3 Global Hematology Diagnostics Market: Opportunity Map

Section 04 Market Overview

4.1 Overview

4.2 Global Hematology Diagnostics Market Size (US$ Mn) Forecast, 2016–2026

4.3 Global Hematology Diagnostics Market Outlook

4.4 Global Hematology Diagnostics Market: Porter’s Five Forces Analysis

4.5 Hematology Analyzers Installed Base

4.6 Key Success factor for Top 3 Players

4.7 Technological Advancements

4.8 Disease Prevalence & Incidence Rate Globally with Key Countries

Section 05 Market Dynamics

5.1 Drivers

5.2 Restraints

5.3 Opportunity Analysis

5.4 Opportunities

5.5 Trends

Section 06 Hematology Diagnostics Market Analysis, by Product Type

6.1 Introduction

6.2 Global Hematology Diagnostics Market Value Share Analysis, by Product Type

6.3 Hematology Diagnostics Market Analysis, by Product Type 

      6.3.1 Hematology Instruments

              6.3.1.1 Hematology Analyzers

                        6.3.1.1.1 Fully-automated Hematology Analyzers

                        6.3.1.1.2 Semi-automated Hematology Analyzers 

              6.3.1.2 Flow Cytometers

              6.3.1.3 Others

      6.3.2 Hematology Consumables

              6.3.2.1 Reagents

              6.3.2.2 Stains

              6.3.2.3 Controls & Calibrators

              6.3.2.4 Others

6.4 Hematology Diagnostics Market Attractiveness Analysis, by Product Type 

6.5 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Analyzers

6.6 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables

Section 07 Hematology Diagnostics Market Analysis, by End-user

7.1 Introduction

7.2 Global Hematology Diagnostics Market Value Share Analysis, by End-user

7.3 Hematology Diagnostics Market Analysis, by End-user

      7.3.1 Diagnostic Laboratories

      7.3.2 Hospitals & Clinics

      7.3.3 Academic Institutes

      7.3.4 Others

7.4 Hematology Diagnostics Market Attractiveness Analysis, by End-user

Section 08 Hematology Diagnostics Market Analysis, by Region

8.1 Global Hematology Diagnostics Market Snapshot, by Country

8.2 Global Hematology Diagnostics Market Value Share Analysis, by Region

8.3 Hematology Diagnostics Market Forecast, by Region

      8.3.1 North America

      8.3.2 Europe

      8.3.3 Asia Pacific

      8.3.4 Latin America

      8.3.5 Middle East & Africa

8.4 Hematology Diagnostics Market Attractiveness Analysis, by Region

8.5 Hematology Diagnostics Market: Regional Trends

Section 09 North America Hematology Diagnostics Market Analysis

9.1 Key Findings

9.2 North America Hematology Diagnostics Market Overview

9.3 North America Market Value Share Analysis, by Product Type

9.4 North America Market Forecast, by Product Type

      9.4.1 Hematology Instruments

      9.4.2 Hematology Consumables

9.5 North America Market Value Share Analysis, by Hematology Instruments

9.6 North America Market Forecast, by Hematology Instruments

      9.6.1 Hematology Analyzers

      9.6.2 Flow Cytometers

      9.6.3 Others

9.7 North America Market Value Share Analysis, by Hematology Consumables

9.8 North America Market Forecast, by Hematology Consumables

      9.8.1 Reagents

      9.8.2 Stains

      9.8.3 Controls & Calibrators

      9.8.4 Others

9.9 North America Market Value Share Analysis, by End-user

9.10 North America Market Forecast, by End-user

      9.10.1 Diagnostic Laboratories

      9.10.2 Hospitals & Clinics

      9.10.3 Academic Institutes

      9.10.4 Others

9.11 Market Analysis, by Country

9.12 Market Value Share Analysis, by Country

9.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026

      9.13.1 U.S.

      9.13.2 Canada

9.14 Market Attractiveness Analysis

      9.14.1 by Product Type

      9.14.2 by Hematology Instruments

      9.14.3 by Hematology Consumables

      9.14.4 by End-user

      9.14.5 by Country

Section 10 Europe Hematology Diagnostics Market Analysis

10.1 Key Findings

10.2 Europe Hematology Diagnostics Market Overview

10.3 Europe Market Value Share Analysis, by Product Type

10.4 Europe Market Forecast, by Product Type

      10.4.1 Hematology Instruments

      10.4.2 Hematology Consumables

10.5 Europe Market Value Share Analysis, by Hematology Instruments

10.6 Europe Market Forecast, by Hematology Instruments

      10.6.1 Hematology Analyzers

      10.6.2 Flow Cytometers

      10.6.3 Others

10.7 Europe Market Value Share Analysis, by Hematology Consumables

10.8 Europe Market Forecast, by Hematology Consumables

      10.8.1 Reagents

      10.8.2 Stains

      10.8.3 Controls & Calibrators

      10.8.4 Others

10.9 Europe Market Value Share Analysis, by End-user

10.10 Europe Market Forecast, by End-user

      10.10.1 Diagnostic Laboratories

      10.10.2 Hospitals & Clinics

      10.10.3 Academic Institutes

      10.10.4 Others

10.11 Market Analysis, by Country

10.12 Market Value Share Analysis, by Country

10.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026

      10.13.1 Germany

      10.13.2 France

      10.13.3 U.K.

      10.13.4 Italy

      10.13.5 Spain

      10.13.6 Rest of Europe

10.14 Market Attractiveness Analysis

      10.14.1 by Product Type

      10.14.2 by Hematology Instruments

      10.14.3 by Hematology Consumables

      10.14.4 by End-user

      10.14.5 by Country

Section 11 Asia Pacific Hematology Diagnostics Market Analysis

11.1 Key Findings

11.2 Asia Pacific Hematology Diagnostics Market Overview

11.3 Asia Pacific Market Value Share Analysis, by Product Type

11.4 Asia Pacific Market Forecast, by Product Type

      11.4.1 Hematology Instruments

      11.4.2 Hematology Consumables

11.5 Asia Pacific Market Value Share Analysis, by Hematology Instruments

11.6 Asia Pacific Market Forecast, by Hematology Instruments

      11.6.1 Hematology Analyzers

      11.6.2 Flow Cytometers

      11.6.3 Others

11.7 Asia Pacific Market Value Share Analysis, by Hematology Consumables

11.8 Asia Pacific Market Forecast, by Hematology Consumables

      11.8.1 Reagents

      11.8.2 Stains

      11.8.3 Controls & Calibrators

      11.8.4 Others

11.9 Asia Pacific Market Value Share Analysis, by End-user

11.10 Asia Pacific Market Forecast, by End-user

      11.10.1 Diagnostic Laboratories

      11.10.2 Hospitals & Clinics

      11.10.3 Academic Institutes

      11.10.4 Others

11.11 Market Analysis, by Country

11.12 Market Value Share Analysis, by Country

11.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026

      11.13.1 China

      11.13.2 Japan

      11.13.3 India

      11.13.4 Australia & New Zealand

      11.13.5 Rest of Asia Pacific

11.14 Market Attractiveness Analysis

      11.14.1 by Product Type

      11.14.2 by Hematology Instruments

      11.14.3 by Hematology Consumables

      11.14.4 by End-user

      11.14.5 by Country

Section 12 Latin America Hematology Diagnostics Market Analysis

12.1 Key Findings

12.2 Latin America Hematology Diagnostics Market Overview

12.3 Latin America Market Value Share Analysis, by Product Type

12.4 Latin America Market Forecast, by Product Type

      12.4.1 Hematology Instruments

      12.4.2 Hematology Consumables

12.5 Latin America Market Value Share Analysis, by Hematology Instruments

12.6 Latin America Market Forecast, by Hematology Instruments

      12.6.1 Hematology Analyzers

      12.6.2 Flow Cytometers

      12.6.3 Others

12.7 Latin America Market Value Share Analysis, by Hematology Consumables

12.8 Latin America Market Forecast, by Hematology Consumables

      12.8.1 Reagents

      12.8.2 Stains

      12.8.3 Controls & Calibrators

      12.8.4 Others

12.9 Latin America Market Value Share Analysis, by End-user

12.10 Latin America Market Forecast, by End-user

      12.10.1 Diagnostic Laboratories

      12.10.2 Hospitals & Clinics

      12.10.3 Academic Institutes

      12.10.4 Others

12.11 Market Analysis, by Country

12.12 Market Value Share Analysis, by Country

12.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026

      12.13.1 Brazil

      12.13.2 Mexico

      12.13.3 Rest of Latin America

12.14 Market Attractiveness Analysis

      12.14.1 by Product Type

      12.14.2 by Hematology Instruments

      12.14.3 by Hematology Consumables

      12.14.4 by End-user

      12.14.5 by Country

Section 13 Middle East & Africa Hematology Diagnostics Market Analysis

13.1 Key Findings

13.2 Middle East & Africa Hematology Diagnostics Market Overview

13.3 Middle East & Africa Market Value Share Analysis, by Product Type

13.4 Middle East & Africa Market Forecast, by Product Type

      13.4.1 Hematology Instruments

      13.4.2 Hematology Consumables

13.5 Middle East & Africa Market Value Share Analysis, by Hematology Instruments

13.6 Middle East & Africa Market Forecast, by Hematology Instruments

      13.6.1 Hematology Analyzers

      13.6.2 Flow Cytometers

      13.6.3 Others

13.7 Middle East & Africa Market Value Share Analysis, by Hematology Consumables

13.8 Middle East & Africa Market Forecast, by Hematology Consumables

      13.8.1 Reagents

      13.8.2 Stains

      13.8.3 Controls & Calibrators

      13.8.4 Others

13.9 Middle East & Africa Market Value Share Analysis, by End-user

13.10 Middle East & Africa Market Forecast, by End-user

      13.10.1 Diagnostic Laboratories

      13.10.2 Hospitals & Clinics

      13.10.3 Academic Institutes

      13.10.4 Others

13.11 Market Analysis, by Country

13.12 Market Value Share Analysis, by Country

13.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026

      13.13.1 GCC Countries

      13.13.2 South Africa

      13.13.3 Rest of Middle East & Africa

13.14 Market Attractiveness Analysis

      13.14.1 By Product Type

      13.14.2 by Hematology Instruments

      13.14.3 by Hematology Consumables

      13.14.4 by End-user

      13.14.5 by Country

Section 14 Competition Landscape

14.1 Competition Matrix

14.2 Hematology Diagnostics Market Share Analysis, by Company (2017)

14.3 Company Profiles

      14.3.1 Abbott Laboratories

             14.3.1.1 Company Description

             14.3.1.2 Financial Overview

             14.3.1.3 Strategy & Recent Developments

             14.3.1.4 SWOT Analysis

      14.3.2 Bio-Rad Laboratories, Inc.

             14.3.2.1 Company Description

             14.3.2.2 Financial Overview

             14.3.2.3 Strategy & Recent Developments

             14.3.2.4 SWOT Analysis

      14.3.3 Sysmex Corporation

             14.3.3.1 Company Description

             14.3.3.2 Financial Overview

             14.3.3.3 Strategy & Recent Developments

             14.3.3.4 SWOT Analysis

     14.3.4 Mindray Medical International Limited

             14.3.4.1 Company Description

             14.3.4.2 Financial Overview

             14.3.4.3 Strategy & Recent Developments

             14.3.4.4 SWOT Analysis

     14.3.5 Siemens Healthineers

             14.3.5.1 Company Description

             14.3.5.2 Financial Overview

             14.3.5.3 Strategy & Recent Developments

             14.3.5.4 SWOT Analysis

      14.3.6 F. Hoffmann-La Roche Ltd. 

             14.3.6.1 Company Description

             14.3.6.2 Financial Overview

             14.3.6.3 Strategy & Recent Developments

             14.3.6.4 SWOT Analysis

     14.3.7 HORIBA, Ltd. 

             14.3.7.1 Company Description

             14.3.7.2 Financial Overview

             14.3.7.3 Strategy & Recent Developments

             14.3.7.4 SWOT Analysis

     14.3.8 HemoCue AB

             14.3.8.1 Company Description

             14.3.8.2 Financial Overview

             14.3.8.3 Strategy & Recent Developments

             14.3.8.4 SWOT Analysis

     14.3.9 Danaher (Beckman Coulter, Inc.)

             14.3.9.1 Company Description

             14.3.9.2 Financial Overview

             14.3.9.3 Strategy & Recent Developments

             14.3.9.4 SWOT Analysis

     14.3.10 Nihon Kohden Corporation

             14.3.10.1 Company Description

             14.3.10.2 Financial Overview

             14.3.10.3 Strategy & Recent Developments

             14.3.10.4 SWOT Analysis

     14.3.11 EKF Diagnostics

             14.3.11.1 Company Description

             14.3.11.2 Financial Overview

             14.3.11.3 Strategy & Recent Developments

             14.3.11.4 SWOT Analysis

     14.3.12 Ortho Clinical Diagnostics

             14.3.12.1 Company Description

             14.3.12.2 Financial Overview

             14.3.12.3 Strategy & Recent Developments

             14.3.12.4 SWOT Analysis

     14.3.13 Drew Scientific

             14.3.13.1 Company Description

             14.3.13.2 Financial Overview

             14.3.13.3 Strategy & Recent Developments

             14.3.13.4 SWOT Analysis

Hematology Diagnostics Market Reports - List of Tables

Table 01: Global Hematology diagnostics Market Analysis, by Installed Base

Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026

Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026

Table 04: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026

Table 05: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026

Table 06: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

Table 07: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2026

Table 08: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2026

Table 09: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026

Table 10: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026

Table 11: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026

Table 12: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026

Table 13: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

Table 14: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

Table 15: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026

Table 16: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026

Table 17: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026

Table 18: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026

Table 19: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

Table 20: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

Table 21: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026

Table 22: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026

Table 23: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026

Table 24: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026

Table 25: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

Table 26: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

Table 27: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026

Table 28: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026

Table 29: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026

Table 30: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026

Table 31: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

Table 32: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

Table 33: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026

Table 34: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026

Table 35: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026

Table 36: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026

Table 37: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026

Hematology Diagnostics Market Reports - List of Figures

Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026

Figure 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 03: Hematology Diagnostics Market Value Share, by Product Type, 2017

Figure 04: Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017

Figure 05: Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017

Figure 06: Hematology Diagnostics Market Value Share, by Region, 2017

Figure 07: Expected New Cases of Leukemia, Lymphoma, or Myeloma in 2017

Figure 08: Global Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026

Figure 09: Global Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026

Figure 10: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Analyzers, 2016–2026

Figure 11: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometers, 2016–2026

Figure 12: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 13: Global Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026

Figure 14: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2016–2026

Figure 15: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stains, 2016–2026

Figure 16: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Controls & Calibrators, 2016–2026

Figure 17: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 19: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Instruments, 2018–2026

Figure 18: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2018–2026

Figure 20: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables, 2018–2026

Figure 21: Global Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026

Figure 22: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026

Figure 23: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2016–2026

Figure 24: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic Institutes, 2016–2026

Figure 25: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 26: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2018–2026

Figure 27: Global Hematology Diagnostics Market Value Share, by Region, 2017 and 2026

Figure 28: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2018–2026

Figure 29: North America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 30: North America Hematology Diagnostics Market Value Share, by Country, 2017 and 2026

Figure 31: North America Hematology Diagnostics Market Attractiveness, by Country, 2018–2026

Figure 32: North America Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026

Figure 33: North America Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026

Figure 34: North America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026

Figure 35: North America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026

Figure 36: North America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026

Figure 37: North America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026

Figure 38: North America Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026

Figure 39: North America Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026

Figure 40: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 41: Europe Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 42: Europe Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 43: Europe Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026

Figure 44: Europe Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026

Figure 45: Europe Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026

Figure 46: Europe Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026

Figure 47: Europe Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026

Figure 48: Europe Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026

Figure 49: Europe Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026

Figure 50: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026

Figure 51: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 52: Asia Pacific Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 53: Asia Pacific Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 54: Asia Pacific Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026

Figure 55: Asia Pacific Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026

Figure 56: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026

Figure 57: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026

Figure 58: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026

Figure 59: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026

Figure 60: Asia Pacific Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026

Figure 61: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026

Figure 62: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 63: Latin America Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 64: Latin America Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 65: Latin America Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026

Figure 66: Latin America Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026

Figure 67: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026

Figure 68: Latin America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026

Figure 69: Latin America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026

Figure 70: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026

Figure 71: Latin America Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026

Figure 72: Latin America Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026

Figure 73: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 74: Middle East & Africa Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 75: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 76: Middle East & Africa Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026

Figure 77: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026

Figure 78: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026

Figure 79: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026

Figure 80: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026

Figure 81: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026

Figure 82: Middle East & Africa Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026

Figure 83: Middle East & Africa Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026